Suppressing Mesenchymal Stromal Cell Ferroptosis Via Targeting a Metabolism‐Epigenetics Axis Corrects their Poor Retention and Insufficient Healing Benefits in the Injured Liver Milieu

Mesenchymal stromal cell (MSC) implantation is a promising option for liver repair, but their poor retention in the injured liver milieu critically blunts therapeutic effects. The aim is to clarify the mechanisms underlying massive MSC loss post‐implantation and establish corresponding improvement s...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Guangyu, Cui, Zhe, Chen, Xiyao, Sun, Fangfang, Li, Tongzheng, Li, Congye, Zhang, Ling, Guo, Xiong, Zhao, Hang, Xia, Yunlong, Yan, Wenjun, Yi, Wei, Fan, Miaomiao, Yang, Rongjin, Wang, Shan, Tao, Ling, Zhang, Fuyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161111/
https://www.ncbi.nlm.nih.gov/pubmed/36808838
http://dx.doi.org/10.1002/advs.202206439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161111/
https://www.ncbi.nlm.nih.gov/pubmed/36808838
http://dx.doi.org/10.1002/advs.202206439

Ejemplares similares